{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:15:56Z","timestamp":1795209356048,"version":"4.10.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02302-y","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:45:08Z","timestamp":1779194708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cryoablation for early-stage invasive breast cancer: pathologic and imaging outcomes from the prospective FIRST trial"],"prefix":"10.1186","volume":"28","author":[{"given":"Vanessa Monteiro","family":"Sanvido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio Eduardo","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Fl\u00e1via Logullo","family":"Waitzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackeline Oliveira","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Galv\u00e3o","family":"Barbante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Ricardo","family":"Socolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna Mayumi Takaki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Rahal","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiris Abait","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina do Lago","family":"Negrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana Vieira do Nascimento","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato Hideo Nakagawa","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Martinez","family":"Vianna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard Medeiros","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Biasi","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afonso Celso Pinto","family":"Naz\u00e1rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"2302_CR1","doi-asserted-by":"publisher","first-page":"622621","DOI":"10.3389\/fonc.2021.622621","volume":"11","author":"S Keelan","year":"2021","unstructured":"Keelan S, Flanagan M, Hill ADK. Evolving trends in surgical management of breast cancer: an analysis of 30 years of practice changing papers. Front Oncol. 2021;11:622621. https:\/\/doi.org\/10.3389\/fonc.2021.622621.","journal-title":"Front Oncol"},{"issue":"2","key":"2302_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.23736\/S2724-5691.22.09820-3","volume":"78","author":"A Fancellu","year":"2023","unstructured":"Fancellu A, Porzani S, Prior M, Cottu P, Giuliani G, Sanna V, Porcu A. Breast-conserving therapy leads to better survival outcomes compared to mastectomy in patients with early breast cancer: evidences from the recent literature. Minerva Surg. 2023;78(2):183\u201393. https:\/\/doi.org\/10.23736\/S2724-5691.22.09820-3.","journal-title":"Minerva Surg"},{"issue":"3","key":"2302_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American college of surgeons oncology group Z0011 randomized trial. Ann Surg. 2010;252(3):426\u201332. https:\/\/doi.org\/10.1097\/SLA.0b013e3181f08f32. discussion 432-3.","journal-title":"Ann Surg"},{"issue":"10","key":"2302_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326. https:\/\/doi.org\/10.1001\/jama.2017.11470.","journal-title":"JAMA"},{"issue":"11","key":"2302_CR5","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","volume":"9","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, Luini A, Viale G, Cassano E, Peradze N, Toesca A, Massari G, Sacchini V, Munzone E, Leonardi MC, Cattadori F, Di Micco R, Esposito E, Sgarella A, Cattaneo S, Busani M, Dessena M, Bianchi A, Cretella E, Ripoll Orts F, Mueller M, Tinterri C, Chahuan Manzur BJ, Benedetto C, Veronesi P. SOUND trial group. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. 2023;9(11):1557\u201364. https:\/\/doi.org\/10.1001\/jamaoncol.2023.3759.","journal-title":"JAMA Oncol"},{"issue":"11","key":"2302_CR6","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","volume":"392","author":"T Reimer","year":"2025","unstructured":"Reimer T, Stachs A, Veselinovic K, K\u00fchn T, Heil J, Polata S, Marm\u00e9 F, M\u00fcller T, Hildebrandt G, Krug D, Ataseven B, Reitsamer R, Ruth S, Denkert C, Bekes I, Zahm DM, Thill M, Golatta M, Holtschmidt J, Knauer M, Nekljudova V, Loibl S, Gerber B. Axillary surgery in breast cancer\u2013primary results of the INSEMA trial. N Engl J Med. 2025;392(11):1051\u201364. https:\/\/doi.org\/10.1056\/NEJMoa2412063.","journal-title":"N Engl J Med"},{"issue":"1157","key":"2302_CR7","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/bjr\/tqae028","volume":"97","author":"M Mactier","year":"2024","unstructured":"Mactier M, McIntosh SA, Sharma N. Minimally invasive treatment of early, good prognosis breast cancer-is this feasible? Br J Radiol. 2024;97(1157):886\u201393. https:\/\/doi.org\/10.1093\/bjr\/tqae028.","journal-title":"Br J Radiol"},{"issue":"7","key":"2302_CR8","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, Colombet M, Pi\u00f1eros M, Znaor A, Parkin DM, Soerjomataram I, Bray F. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025;156(7):1336\u201346. https:\/\/doi.org\/10.1002\/ijc.35278.","journal-title":"Int J Cancer"},{"issue":"15","key":"2302_CR9","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1056\/NEJMoa1600249","volume":"375","author":"HG Welch","year":"2016","unstructured":"Welch HG, Prorok PC, O\u2019Malley AJ, Kramer BS. Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness. N Engl J Med. 2016;375(15):1438\u201347. https:\/\/doi.org\/10.1056\/NEJMoa1600249.","journal-title":"N Engl J Med"},{"key":"2302_CR10","doi-asserted-by":"crossref","unstructured":"Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM. Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology. 2014;68(1):1\u201311.","DOI":"10.1016\/j.cryobiol.2013.11.001"},{"issue":"2","key":"2302_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jamcollsurg.2007.03.007","volume":"205","author":"AA Gage","year":"2007","unstructured":"Gage AA, Baust JG. Cryosurgery for tumors. J Am Coll Surg. 2007;205(2):342\u201356. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2007.03.007.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"2302_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s10147-019-01448-4","volume":"24","author":"M Takada","year":"2019","unstructured":"Takada M, Toi M. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. Int J Clin Oncol. 2019;24(6):608\u201313. https:\/\/doi.org\/10.1007\/s10147-019-01448-4.","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"2302_CR13","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1245\/s10434-016-5275-3","volume":"23","author":"RM Simmons","year":"2016","unstructured":"Simmons RM, Ballman KV, Cox C, Carp N, Sabol J, Hwang RF, Attai D, Sabel M, Nathanson D, Kenler A, Gold L, Kaufman C, Han L, Bleznak A, Stanley Smith J, Holmes D, Fornage B, Le-Petross C, Hoda S, McCall L, Hunt KK. ACOSOG investigators. A phase II trial exploring the success of cryoablation therapy in the treatment of invasive breast carcinoma: results from ACOSOG (Alliance) Z1072. Ann Surg Oncol. 2016;23(8):2438\u201345. https:\/\/doi.org\/10.1245\/s10434-016-5275-3.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"2302_CR14","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1245\/s10434-021-10501-4","volume":"28","author":"RE Fine","year":"2021","unstructured":"Fine RE, Gilmore RC, Dietz JR, Boolbol SK, Berry MP, Han LK, Kenler AS, Sabel M, Tomkovich KR, VanderWalde NA, Chen M, Columbus KS, Curcio LD, Feldman SM, Gold L, Hernandez L, Manahan ER, Seedman SA, Vaidya RP, Sevrukov AB, Aoun HD, Hicks RD, Simmons RM. Cryoablation without excision for low-risk early-stage breast cancer: 3-year interim analysis of ipsilateral breast tumor recurrence in the ICE3 trial. Ann Surg Oncol. 2021;28(10):5525\u201334. https:\/\/doi.org\/10.1245\/s10434-021-10501-4.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"2302_CR15","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1245\/s10434-024-16181-0","volume":"31","author":"RE Fine","year":"2024","unstructured":"Fine RE, Gilmore RC, Tomkovich KR, Dietz JR, Berry MP, Hernandez LE, Columbus KS, Seedman SA, Fisher CS, Han LK, Manahan ER, Hicks RD, Vaidya RP, Curcio LD, Sevrukov AB, Kenler AS, Taback B, Chen M, Miller ME, Gold L, Anglin BV, Aoun HD, Simmons RM, Feldman SM, Boolbol SK. Cryoablation without excision for early-stage breast cancer: ICE3 trial 5-year follow-up on ipsilateral breast tumor recurrence. Ann Surg Oncol. 2024;31(11):7273\u201383. https:\/\/doi.org\/10.1245\/s10434-024-16181-0.","journal-title":"Ann Surg Oncol"},{"key":"2302_CR16","doi-asserted-by":"crossref","unstructured":"Khan SY, Cole J, Habrawi Z, Melkus MW, Layeequr Rahman R. Cryoablation allows the ultimate De-escalation of surgical therapy for select breast cancer patients. Ann Surg Oncol. 2023;30(13):8398\u2013403.","DOI":"10.1245\/s10434-023-14332-3"},{"issue":"6","key":"2302_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jnci\/djr027","volume":"103","author":"IL Wapnir","year":"2011","unstructured":"Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP, Wolmark N. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103(6):478\u201388. https:\/\/doi.org\/10.1093\/jnci\/djr027.","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"2302_CR18","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa022152","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233\u201341. https:\/\/doi.org\/10.1056\/NEJMoa022152.","journal-title":"N Engl J Med"},{"issue":"10","key":"2302_CR19","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/jamaoncol.2017.0774","volume":"3","author":"M Morrow","year":"2017","unstructured":"Morrow M, Abrahamse P, Hofer TP, Ward KC, Hamilton AS, Kurian AW, Katz SJ, Jagsi R. Trends in reoperation after initial lumpectomy for breast cancer: addressing overtreatment in surgical management. JAMA Oncol. 2017;3(10):1352\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0774.","journal-title":"JAMA Oncol"},{"issue":"10","key":"2302_CR20","doi-asserted-by":"publisher","first-page":"e203025","DOI":"10.1001\/jamasurg.2020.3025","volume":"155","author":"ML Marinovich","year":"2020","unstructured":"Marinovich ML, Noguchi N, Morrow M, Houssami N. Changes in reoperation after publication of consensus guidelines on margins for breast-conserving surgery: a systematic review and meta-analysis. JAMA Surg. 2020;155(10):e203025. https:\/\/doi.org\/10.1001\/jamasurg.2020.3025.","journal-title":"JAMA Surg"},{"issue":"10","key":"2302_CR21","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.jvir.2009.06.029","volume":"20","author":"PJ Littrup","year":"2009","unstructured":"Littrup PJ, Jallad B, Chandiwala-Mody P, D\u2019Agostini M, Adam BA, Bouwman D. Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol. 2009;20(10):1329\u201341. https:\/\/doi.org\/10.1016\/j.jvir.2009.06.029.","journal-title":"J Vasc Interv Radiol"},{"issue":"11","key":"2302_CR22","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jama.2024.26698","volume":"333","author":"ES Hwang","year":"2025","unstructured":"Hwang ES, Hyslop T, Lynch T, Ryser MD, Weiss A, Wolf A, Norris K, Witten M, Grimm L, Schnitt S, Badve S, Factor R, Frank E, Collyar D, Basila D, Pinto D, Watson MA, West R, Davies L, Donovan JL, Shimada A, Li Y, Li Y, Bennett AV, Rosenberg S, Marks J, Winer E, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Carey LA, Thompson AM, Partridge AH. COMET study investigators. Active monitoring with or without endocrine therapy for low-risk ductal carcinoma in situ: the COMET randomized clinical trial. JAMA. 2025;333(11):972\u201380. https:\/\/doi.org\/10.1001\/jama.2024.26698.","journal-title":"JAMA"},{"issue":"16","key":"2302_CR23","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JM, Brookes C, Roberts T, Pirrie S, Gaunt C, Young J, Billingham L, Dodwell D, Hanby A, Pinder SE, Evans A, Reed M, Jenkins V, Matthews L, Wilcox M, Fairbrother P, Bowden S, Rea D. Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer. 2015;51(16):2296\u2013303. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.017.","journal-title":"Eur J Cancer"},{"key":"2302_CR24","doi-asserted-by":"publisher","first-page":"103764","DOI":"10.1016\/j.breast.2024.103764","volume":"77","author":"EG Engelhardt","year":"2024","unstructured":"Engelhardt EG, Schmitz RSJM, Gerritsma MA, Sondermeijer CMT, Verschuur E, Houtzager JHE, Griffioen R, Bijker N, Mann RM, Ret\u00e8l V, van Duijnhoven FH, Wesseling J, Bleiker EMA. Grand challenge PRECISION consortium. DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS. Breast. 2024;77:103764. https:\/\/doi.org\/10.1016\/j.breast.2024.103764.","journal-title":"Breast"},{"issue":"3","key":"2302_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10549-024-07325-7","volume":"206","author":"MJ Roca Navarro","year":"2024","unstructured":"Roca Navarro MJ, Oliver Goldaracena JM, Garrido Alonso D, Navarro Monforte Y, D\u00edaz de Bustamante Durb\u00e1n T, C\u00f3rdoba Chicote MV, Garc\u00eda Mart\u00ednez F, Mart\u00ed \u00c1lvarez C, Y\u00e9benes Gregorio L, Montes Botella JL. Mart\u00edn Herv\u00e1s C, S\u00e1nchez M\u00e9ndez JI. Pre-surgical cryoablation in \u2264\u20092\u00a0cm ER + \/HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma. Breast Cancer Res Treat. 2024;206(3):561\u201373. https:\/\/doi.org\/10.1007\/s10549-024-07325-7.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"2302_CR26","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.3390\/biomedicines13122987","volume":"13","author":"KL Lee","year":"2025","unstructured":"Lee KL, Sule AA, Lai HX, Ng QX, Goh SSN. Cryotherapy as a surgical De-Escalation strategy in breast cancer: techniques, complications, and oncological outcomes. Biomedicines. 2025;13(12):2987. https:\/\/doi.org\/10.3390\/biomedicines13122987.","journal-title":"Biomedicines"},{"issue":"4","key":"2302_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12282-024-01584-4","volume":"31","author":"H Kawamoto","year":"2024","unstructured":"Kawamoto H, Tsugawa K, Furuya Y, Sakamaki K, Kakimoto S, Kitajima M, Takishita MN, Tazo M, Nakano MH, Kuroda T, Shimo A, Shimo A, Kojima Y, Tsuzuki M, Motoyoshi A, Haku E, Nishikawa T, Kanemaki Y, Mimura H, Fukuda M. Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan. Breast Cancer. 2024;31(4):695\u2013704. https:\/\/doi.org\/10.1007\/s12282-024-01584-4.","journal-title":"Breast Cancer"},{"issue":"6","key":"2302_CR28","doi-asserted-by":"publisher","first-page":"e715","DOI":"10.1016\/j.clbc.2021.03.004","volume":"21","author":"EMF van de Voort","year":"2021","unstructured":"van de Voort EMF, Struik GM, Birnie E, Moelker A, Verhoef C, Klem TMAL. Thermal ablation as an alternative for surgical resection of small (\u2264\u20092\u00a0cm) breast cancers: a meta-analysis. Clin Breast Cancer. 2021;21(6):e715\u201330. https:\/\/doi.org\/10.1016\/j.clbc.2021.03.004.","journal-title":"Clin Breast Cancer"},{"key":"2302_CR29","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.urology.2016.02.012","volume":"91","author":"TT Shah","year":"2016","unstructured":"Shah TT, Arbel U, Foss S, Zachman A, Rodney S, Ahmed HU, Arya M. Modeling cryotherapy ice ball dimensions and isotherms in a novel gel-based model to determine optimal cryo-needle configurations and settings for potential use in clinical practice. Urology. 2016;91:234\u201340. https:\/\/doi.org\/10.1016\/j.urology.2016.02.012.","journal-title":"Urology"},{"key":"2302_CR30","doi-asserted-by":"publisher","first-page":"930461","DOI":"10.3389\/fimmu.2022.930461","volume":"13","author":"Y Wu","year":"2022","unstructured":"Wu Y, Cao F, Zhou D, Chen S, Qi H, Huang T, Tan H, Shen L, Fan W. Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity. Front Immunol. 2022;13:930461. https:\/\/doi.org\/10.3389\/fimmu.2022.930461.","journal-title":"Front Immunol"},{"key":"2302_CR31","doi-asserted-by":"publisher","first-page":"1469684","DOI":"10.3389\/fonc.2025.1469684","volume":"15","author":"Y Xing","year":"2025","unstructured":"Xing Y, Li H, Yuan T, Zou X, Liang B, Ma Y, Niu L. Cryoablation in the treatment of early breast cancer: a comprehensive analysis. Front Oncol. 2025;15:1469684. https:\/\/doi.org\/10.3389\/fonc.2025.1469684.","journal-title":"Front Oncol"},{"issue":"3","key":"2302_CR32","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1016\/S1470-2045(23)00615-0","volume":"25","author":"M Toi","year":"2024","unstructured":"Toi M, Kinoshita T, Benson JR, Jatoi I, Kataoka M, Han W, Yamauchi C, Inamoto T, Takada M. Non-surgical ablation for breast cancer: an emerging therapeutic option. Lancet Oncol. 2024;25(3):e114\u201325. https:\/\/doi.org\/10.1016\/S1470-2045(23)00615-0.","journal-title":"Lancet Oncol"},{"issue":"3","key":"2302_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/CEJ.0000000000000936","volume":"34","author":"M Intra","year":"2025","unstructured":"Intra M, Magnoni F, Della Vigna P, Nicosia L, Mazzarol G, Galimberti V, Orsi F, Veronesi P. Cryoablation of early breast cancer: the challenge towards de-escalation of surgical treatment. Eur J Cancer Prev. 2025;34(3):264\u20136. https:\/\/doi.org\/10.1097\/CEJ.0000000000000936.","journal-title":"Eur J Cancer Prev"},{"key":"2302_CR34","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1245\/s10434-022-12570-5","volume":"30","author":"SY Khan","year":"2023","unstructured":"Khan SY, et al. The role of cryoablation in breast cancer beyond the oncologic control: COST and breast-Q patient-reported outcomes. Ann Surg Oncol. 2023;30:1029\u201337. https:\/\/doi.org\/10.1245\/s10434-022-12570-5.","journal-title":"Ann Surg Oncol"},{"key":"2302_CR35","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3390\/life13081756","volume":"13","author":"D Holmes","year":"2023","unstructured":"Holmes D, Iyengar G. Breast cancer cryoablation in the multidisciplinary setting: practical guidelines for patients and physicians. Life. 2023;13:1756. https:\/\/doi.org\/10.3390\/life13081756.","journal-title":"Life"},{"issue":"1","key":"2302_CR36","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1245\/s10434-023-14335-0","volume":"31","author":"MW Melkus","year":"2024","unstructured":"Melkus MW, Khan SY, Cole J, Layeequr Rahman R. ASO author reflections: achieving surgical De-Escalation of breast cancer through cryoablation. Ann Surg Oncol. 2024;31(1):384\u20135. https:\/\/doi.org\/10.1245\/s10434-023-14335-0.","journal-title":"Ann Surg Oncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02302-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02302-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T23:22:14Z","timestamp":1783898534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02302-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2302"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02302-y","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the Universidade Federal de S\u00e3o Paulo (UNIFESP; approval number: 3.270.850; approval date: April 17, 2019), with additional approvals from the Hcor Research Institute and Hospital Israelita Albert Einstein prior to enrollment. All participants provided written informed consent before inclusion in the trial. The study adhered to national and international ethical standards, including the Declaration of Helsinki and Good Clinical Practice guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No identifiable patient information is included in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NCT05398497 (Registration Date 2022-05-26).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trials number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}